189497-34-5

Basic information

• Product Name: tris(2-(6-{1-[1-(benzyloxy)-2-oxo-1,2-dihydropyrimidin-4-yl]amino}octanamido)ethyl)amine
• Synonyms: tris(2-(6-{1-[1-(benzyloxy)-2-oxo-1,2-dihydropyrimidin-4-yl]amino}octanamido)ethyl)amine
• CAS NO: 189497-34-5
• Molecular Weight: 1170.47
• Mol File: 189497-34-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tris(2-(6-{1-[1-(benzyloxy)-2-oxo-1,2-dihydropyrimidin-4-yl]amino}octanamido)ethyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: tris(2-(6-{1-[1-(benzyloxy)-2-oxo-1,2-dihydropyrimidin-4-yl]amino}octanamido)ethyl)amine(189497-34-5)
• EPA Substance Registry System: tris(2-(6-{1-[1-(benzyloxy)-2-oxo-1,2-dihydropyrimidin-4-yl]amino}octanamido)ethyl)amine(189497-34-5)

Safety Data

• Hazardous Substances Data: 189497-34-5(Hazardous Substances Data)

Upstream product

• 189497-20-9 4-{[7-(methoxycarbonyl)heptyl]amino}-1-(benzyloxy)-2(1H)-pyrimidinone 
• 189497-24-3 4-[(7-carboxyheptyl)amino]-1-(benzyloxy)-2(1H)-pyrimidinone 
• 219992-65-1 1-(benzyloxy)-4-(1′,2′,4′-triazol-1′-yl)-2-(1H)-pyrimidinone 
• 721-01-7 1-(benzyloxy)uracil 
• 2048-50-2 benzyloxyurea 
• 4097-89-6 2,2',2''-triaminotriethylamine 
• 189497-28-7 4-[(7-carboxyheptyl)amino]-1-(benzyloxy)-2(1H)-pyrimidinone O-succinimide ester 

Relevant articles and documents

Novel Iron Sequestering Agents: Synthesis and Iron-Chelating Properties of Hexadentate Ligands Composed of 1-Hydroxy-2(1H)-pyrimidinone, ω-Amino Carboxylic Acid, and Tris(2-aminoethyl)amine

Novel heterocyclic hexadentate ligands (3HOPYn: n = 5-7), in which three units of 1-hydroxy-2(1H)-pyrimidinone are linked to tris(2-aminoethyl)amine through an amide bond by an alkyl chain, were synthesized, and their iron-chelating properties were investigated. The stability of their iron complexes (25 to 27 in log K) was significantly larger than that of pyrazinone-containing ligands by virtue of higher pKa values. On kinetic evaluation of iron removal from human transferrin, 3HOPY5 showed remarkable efficiency over five times as much as commercially available desferrioxamine B. The conformational analysis of the corresponding Ga(III) complex of Fe(opy5) by 1H NMR and by MM and MD calculations are also discussed.